ADAG
Price:
$1.895
Market Cap:
$83.89M
Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid tumors and non-Hodgkin's lymphoma; ADG126, a fully-human anti-CTLA-4 mAb that is in Phase 1 clinical trial for the treatment advanced/metastatic solid tumors; and ADG116, a human ligand-blocking anti-CTLA-4 mAb, which is in Phase I clinical trial for the treatment of advanced metastatic solid tumors. It also offers ADG104, an anti-PD-L1 mAb that is in...[Read more]
Industry
Biotechnology
IPO Date
2021-02-09
Stock Exchange
NASDAQ
Ticker
ADAG
According to Adagene Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.63. This represents a change of -20.51% compared to the average of -3.31 of the last 4 quarters.
The mean historical PE Ratio of Adagene Inc. over the last ten years is -36.72. The current -2.63 PE Ratio has changed 616.31% with respect to the historical average. Over the past ten years (40 quarters), ADAG's PE Ratio was at its highest in in the December 2020 quarter at 23.96. The PE Ratio was at its lowest in in the December 2019 quarter at -50.02.
Average
-36.72
Median
-34.24
Minimum
-76.59
Maximum
-0.72
Discovering the peaks and valleys of Adagene Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 521.67%
Maximum Annual PE Ratio = -0.72
Minimum Annual Increase = -93.11%
Minimum Annual PE Ratio = -76.59
Year | PE Ratio | Change |
---|---|---|
2023 | -4.46 | 521.67% |
2022 | -0.72 | -83.74% |
2021 | -4.41 | -93.11% |
2020 | -64.02 | -16.42% |
2019 | -76.59 | 9.26% |
The current PE Ratio of Adagene Inc. (ADAG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.20
5-year avg
-30.04
10-year avg
-36.72
Adagene Inc.’s PE Ratio is less than Aerovate Therapeutics, Inc. (-0.88), greater than Acrivon Therapeutics, Inc. Common Stock (-3.05), greater than Rezolute, Inc. (-4.41), less than AN2 Therapeutics, Inc. (-0.68), greater than Anebulo Pharmaceuticals, Inc. (-3.86), less than AnaptysBio, Inc. (-2.52), greater than Mineralys Therapeutics, Inc. (-4.11), less than Eliem Therapeutics, Inc. (0), greater than Janux Therapeutics, Inc. (-50.81), less than PMV Pharmaceuticals, Inc. (-1.46), less than Molecular Partners AG (-2.46),
Company | PE Ratio | Market cap |
---|---|---|
-0.88 | $74.21M | |
-3.05 | $191.80M | |
-4.41 | $253.79M | |
-0.68 | $41.53M | |
-3.86 | $30.60M | |
-2.52 | $439.09M | |
-4.11 | $628.58M | |
0 | $342.68M | |
-50.81 | $3.25B | |
-1.46 | $75.29M | |
-2.46 | $200.54M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adagene Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Adagene Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Adagene Inc.'s PE Ratio?
How is the PE Ratio calculated for Adagene Inc. (ADAG)?
What is the highest PE Ratio for Adagene Inc. (ADAG)?
What is the 3-year average PE Ratio for Adagene Inc. (ADAG)?
What is the 5-year average PE Ratio for Adagene Inc. (ADAG)?
How does the current PE Ratio for Adagene Inc. (ADAG) compare to its historical average?